Girao Tiago
SEC insider (Form 3/4/5 filer). CIK 0001618670. Chief Financial Officer at Immunovant, Inc. (IMVT). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 23, 2026. Located in DURHAM, NC.
Companies Girao Tiago has filed insider reports for
- Immunovant, Inc. (IMVT): Officer, Chief Financial Officer
Girao Tiago
CIK: 0001618670
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (50.0%)
Position reduction
Option Exercises (M)1 (16.7%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMVT
Immunovant, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 23, 2026IMVT
Immunovant, Inc.
SaleDirect6.8K shares at avg. $38.69$263K - Jun 26, 2026IMVT
Immunovant, Inc.
ExerciseDirect10K shares at avg. $15.90$159K - Jun 26, 2026IMVT
Immunovant, Inc.
SaleDirect10K shares at avg. $38.46$385K - Apr 23, 2026IMVT
Immunovant, Inc.
SaleDirect25.8K shares at avg. $29.62$763K - Apr 7, 2026IMVT
Immunovant, Inc.
AwardDirect65K shares- - May 1, 2025IMVT
Immunovant, Inc.
AwardDirect208.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 23, 2026 | IMVT Immunovant, Inc. | Sale | 6,798 | $38.69 | $263,015 | Direct |
| Jun 26, 2026 | IMVT Immunovant, Inc. | Exercise | 10,000 | $15.90 | $159,000 | Direct |
| Jun 26, 2026 | IMVT Immunovant, Inc. | Sale | 10,000 | $38.46 | $384,600 | Direct |
| Apr 23, 2026 | IMVT Immunovant, Inc. | Sale | 25,760 | $29.62 | $763,011 | Direct |
| Apr 7, 2026 | IMVT Immunovant, Inc. | Award | 64,968 | - | $0 | Direct |
| May 1, 2025 | IMVT Immunovant, Inc. | Award | 208,388 | - | - | Direct |
1-6 of 6 transactions